Explore the vast range of titles available.

\"In White Lies and Black Markets, Fatah-Black offers a new account of the colonization of Suriname--one of the major European plantation colonies on the Guiana Coast--in the period between 1650-1800. While commonly portrayed as an isolated tropical outpost, this study places the colony in the context of its connections to the rest of the Atlantic world. These economic and migratory links assured the colony's survival, but also created many incentives to evade the mercantilistically inclined metropolitan authorities. By combining the available data on Dutch and North American shipping with accounts of major political and economic developments, the author uncovers a hitherto hidden world of illicit dealings, and convincingly argues that these illegal practices were essential to the development and survival of the colony, and woven into the fabric of the colonial project itself\"--Provided by publisher

\"In White Lies and Black Markets, Fatah-Black offers a new account of the colonization of Suriname--one of the major European plantation colonies on the Guiana Coast--in the period between 1650-1800. While commonly portrayed as an isolated tropical outpost, this study places the colony in the context of its connections to the rest of the Atlantic world. These economic and migratory links assured the colony's survival, but also created many incentives to evade the mercantilistically inclined metropolitan authorities. By combining the available data on Dutch and North American shipping with accounts of major political and economic developments, the author uncovers a hitherto hidden world of illicit dealings, and convincingly argues that these illegal practices were essential to the development and survival of the colony, and woven into the fabric of the colonial project itself\"--Provided by publisher.

This study compares mortality and other endpoints between intensive care unit COVID-19 patients treated with convalescent plasma plus standard of care (CCP), and a control group of patients hospitalized in the same medical ICU facility treated with standard of care alone (SOC) in a low- and middle-income country (LMIC) setting using bedside donor whole blood separation by gravity (HemoClear) to produce the CCP. It demonstrates a significant 65% survival improvement in HemoClear-produced CCP recipients (HR, 0.35; 95% CI, 0.19 to 0.66; P = 0.001). Convalescent plasma is a promising therapy for coronavirus disease 2019 (COVID-19), but its efficacy in intensive care unit (ICU) patients in low- and middle-income country settings such as Suriname is unknown. Bedside plasma separation using the HemoClear device made convalescent plasma therapy accessible as a treatment option in Suriname. Two hundred patients with severe SARS-CoV-2 infection requiring intensive care were recruited. Fifty eight patients (29%) received COVID-19 convalescent plasma (CCP) treatment in addition to standard of care (SOC). The CCP treatment and SOC groups were matched by age, sex, and disease severity scores. Mortality in the CCP treatment group was significantly lower than that in the SOC group (21% versus 39%; Fisher’s exact test P = 0.0133). Multivariate analysis using ICU days showed that CCP treatment reduced mortality (hazard ratio [HR], 0.35; 95% confidence interval [CI], 0.18 to 0.66; P = 0.001), while complication of acute renal failure (creatinine levels, >110 mol/L; HR, 4.45; 95% CI, 2.54 to 7.80; P < 0.0001) was independently associated with death. Decrease in chest X-ray score in the CCP treatment group (median −3 points, interquartile range [IQR] −4 to −1) was significantly greater than that in the SOC group (median −1 point, IQR −3 to 1, Mann-Whitney test P = 0.0004). Improvement in the PaO 2 /FiO 2 ratio was also significantly greater in the CCP treatment group (median 83, IQR 8 to 140) than in the SOC group (median 35, IQR −3 to 92, Mann-Whitney P = 0.0234). Further research is needed for HemoClear-produced CCP as a therapy for SARS-CoV-2 infection together with adequately powered, randomized controlled trials. IMPORTANCE This study compares mortality and other endpoints between intensive care unit COVID-19 patients treated with convalescent plasma plus standard of care (CCP), and a control group of patients hospitalized in the same medical ICU facility treated with standard of care alone (SOC) in a low- and middle-income country (LMIC) setting using bedside donor whole blood separation by gravity (HemoClear) to produce the CCP. It demonstrates a significant 65% survival improvement in HemoClear-produced CCP recipients (HR, 0.35; 95% CI, 0.19 to 0.66; P = 0.001). Although this is an exploratory study, it clearly shows the benefit of using the HemoClear-produced CCP in ICU patients in the Suriname LMIC setting. Additional studies could further substantiate our findings and their applicability for both LMICs and high-income countries and the use of CCP as a prepared readiness method to combat new viral pandemics.

Melioidosis, caused by the highly lethal pathogen Burkholderia pseudomallei, is emerging in North and South America. We studied soil samples in Suriname to determine endemicity of Burkholderia species. B. thailandensis was isolated, but B. pseudomallei was not. A multidisciplinary approach could establish clinical and ecologic distribution of both Burholderia species in Suriname.

To evaluate the effect of a practice-based, culturally appropriate patient education intervention on blood pressure (BP) and treatment adherence among patients of African origin with uncontrolled hypertension. Cluster randomised trial involving four Dutch primary care centres and 146 patients (intervention n=75, control n=71), who met the following inclusion criteria: self-identified Surinamese or Ghanaian; ≥ 20 years; treated for hypertension; SBP ≥ 140 mmHg. All patients received usual hypertension care. The intervention-group was also offered three nurse-led, culturally appropriate hypertension education sessions. BP was assessed with Omron 705-IT and treatment adherence with lifestyle- and medication adherence scales. 139 patients (95%) completed the study (intervention n=71, control n=68). Baseline characteristics were largely similar for both groups. At six months, we observed a SBP reduction of ≥ 10 mmHg -primary outcome- in 48% of the intervention group and 43% of the control group. When adjusted for pre-specified covariates age, sex, hypertension duration, education, baseline measurement and clustering effect, the between-group difference was not significant (OR; 0.42; 95% CI: 0.11 to 1.54; P=0.19). At six months, the mean SBP/DBD had dropped by 10/5.7 (SD 14.3/9.2)mmHg in the intervention group and by 6.3/1.7 (SD 13.4/8.6)mmHg in the control group. After adjustment, between-group differences in SBP and DBP reduction were -1.69 mmHg (95% CI: -6.01 to 2.62, P=0.44) and -3.01 mmHg (-5.73 to -0.30, P=0.03) in favour of the intervention group. Mean scores for adherence to lifestyle recommendations increased in the intervention group, but decreased in the control group. Mean medication adherence scores improved slightly in both groups. After adjustment, the between-group difference for adherence to lifestyle recommendations was 0.34 (0.12 to 0.55; P=0.003). For medication adherence it was -0.09 (-0.65 to 0.46; P=0.74). This intervention led to significant improvements in DBP and adherence to lifestyle recommendations, supporting the need for culturally appropriate hypertension care. Controlled-Trials.com ISRCTN35675524.

Abstract This note presents new demographic data on the number and location of \"Suriname Maroons\" in Guyane (French Guiana), as well as elsewhere in the world. After brief discussion of the methodological challenges of estimating the size of \"ethnic\" populations in a country whose census prohibits such counts, it shows that about 38 percent of Maroons now live in Guyane and that they form one-third of the total population. It ends by suggesting some implications of this demographic explosion.